Cargando…

Neurofilament light as a biomarker for motor decline in Parkinson’s disease

OBJECTIVES: The aim of this study was to determine whether neurofifilament light (NfL) could reflect motor decline and compare the predictive values of cerebrospinal fluid (CSF) and serum NfL in individuals with PD. METHODS: CSF/serum samples were collected from patients with PD and healthy controls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yumei, Dou, Kaixin, Xue, Ling, Li, Xiaoyuan, Xie, Anmu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477093/ https://www.ncbi.nlm.nih.gov/pubmed/36117629 http://dx.doi.org/10.3389/fnins.2022.959261

Ejemplares similares

Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
por: Dou, Kaixin, et al.
Publicado: (2022)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)

Associations of striatal dopamine transporter binding with motor and non‐motor symptoms in early Parkinson's disease
por: Yang, Zhengjie, et al.
Publicado: (2023)

Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2022)

Clinical characteristics in early Parkinson's disease with excessive daytime sleepiness: A cross‐sectional and longitudinal study
por: Liu, Yumei, et al.
Publicado: (2023)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis
por: Li, Dawei, et al.
Publicado: (2016)

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
por: Sun, Xiaohui, et al.
Publicado: (2022)

Neurofilament Light Chain as a Biomarker for Monitoring the Efficacy of Transcranial Magnetic Stimulation on Alcohol Use Disorder
por: Zhang, Tian, et al.
Publicado: (2022)

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
por: Loeffler, Tina, et al.
Publicado: (2020)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment
por: Wang, Jian-Hong, et al.
Publicado: (2021)

Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke
por: Zhang, Xiaoting, et al.
Publicado: (2022)

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance
por: Kartau, Marge, et al.
Publicado: (2023)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases
por: Liu, Shunjie, et al.
Publicado: (2020)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis
por: Jin, Mei, et al.
Publicado: (2019)

Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1/TLR4 pathway in a rat model of Parkinson’s disease
por: Han, Chao, et al.
Publicado: (2023)

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
por: Mollenhauer, Brit, et al.
Publicado: (2020)

Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
por: Ren, Jingru, et al.
Publicado: (2023)

Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson’s Disease
por: Yang, Zhengjie, et al.
Publicado: (2021)

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia
por: Yang, Liying, et al.
Publicado: (2018)

Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients
por: Ingannato, Assunta, et al.
Publicado: (2021)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease
por: Ng, Adeline Su Lyn, et al.
Publicado: (2020)

The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
por: Frempong, Bernice, et al.
Publicado: (2021)

Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
por: Yuan, Aidong, et al.
Publicado: (2021)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

White matter hyperintensity, neurofilament light chain, and cognitive decline
por: Dhana, Anisa, et al.
Publicado: (2022)

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
por: Giacomucci, Giulia, et al.
Publicado: (2022)

Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain
por: Gaetani, Lorenzo, et al.
Publicado: (2021)

Region-Specific Neurovascular Decoupling Associated With Cognitive Decline in Parkinson’s Disease
por: Shang, Song’an, et al.
Publicado: (2021)

Plasma Neurofilament Light Chain as a Predictive Biomarker for Post-stroke Cognitive Impairment: A Prospective Cohort Study
por: Wang, Zhiqiang, et al.
Publicado: (2021)

TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X‐linked Dystonia‐Parkinsonism
por: Al Ali, Jamal, et al.
Publicado: (2020)

Investigating Associations Between Inflammatory Biomarkers, Gray Matter, Neurofilament Light and Cognitive Performance in Healthy Older Adults
por: Karoly, Hollis C., et al.
Publicado: (2021)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2023)

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
por: Sheng, Ze-Hu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2n5ttj58clm5o95ihc9j96e87c